Versigent PLC

As of June 30, 2026, Versigent PLC carries a market capitalization of 2.58B, placing it among publicly traded companies globally. Its enterprise value stands at 4.39B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Versigent PLC's next confirmed earnings release is scheduled for November 4, 2026.

As of June 30, 2026, Versigent PLC has 70.82M shares outstanding.

As of June 30, 2026, Versigent PLC trades at a trailing price-to-earnings ratio of 6.08. The price-to-sales ratio is 0.32, and the price-to-book ratio stands at 34.72.

As of June 30, 2026, Versigent PLC trades at an EV/EBITDA multiple of 6.43 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.54 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 9.08 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 4.39B versus a market cap of 2.58B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Versigent PLC maintains a current ratio of 1.40, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 853.17, indicating elevated leverage, while an interest coverage ratio of 19.05 demonstrates strong ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 58,632.41 in revenue per employee across its workforce of 138,000.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Versigent PLC recorded an income tax benefit of -17.51M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 407.01M, leaving 425.40M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

These figures are as of the close on October 22, 2026.

Over the twelve months ended June 30, 2026, Versigent PLC generated 8.09B in revenue and converted that into 425.40M in net income, yielding earnings per share of 6.16. EBITDA reached 683.61M, while operating income came in at 636.34M.

As of June 30, 2026, Versigent PLC holds 484.92M in cash and equivalents against 2.12B in total debt, resulting in a net debt position of 1.46B. Total book value stands at 74.40M, with working capital of 882.30M providing operational flexibility.

Versigent PLC produced 564.57M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Versigent PLC posted a gross margin of 12.28, reflecting its pricing power and cost economics. The operating margin of 7.86 and net profit margin of 5.26 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Versigent PLC paid dividends of 23.37 per share. The dividend payout ratio of 369.92 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 21.81, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 7.42, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Versigent PLC shareholders.

As of June 30, 2026, Versigent PLC has an Altman Z-Score of 2.78, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.